A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

India, March 19 -- Weekly buprenorphine injections demonstrate a superior safety profile compared to daily oral dosing and ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly ...

Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...